How to Help Your Patients Save Money on Methotrexate: A Provider's Guide to Savings Programs

Methotrexate is one of the most cost-effective medications in rheumatology and dermatology — but that doesn't mean every patient can access it affordably. Uninsured patients, those on high-deductible plans, and patients requiring specialty injectable formulations can still face meaningful financial barriers. This guide gives providers a practical toolkit for navigating patient assistance programs and cost-reduction strategies for methotrexate.

Understanding Methotrexate Pricing

Generic oral methotrexate tablets (2.5 mg) are among the least expensive prescription drugs available. The retail price varies widely:

Average retail (no coupon): $15–$110 for a 30-day supply of oral tablets, depending on pharmacy and quantity

With GoodRx coupon: As low as $5 per month at participating pharmacies

With insurance: $0–$30 copay on most commercial plans (Tier 1–2 generic)

Injectable 25 mg/mL: From $7–$44 per vial; often covered under medical benefit for oncology (not pharmacy benefit)

Patients who are on oral methotrexate at standard RA/psoriasis doses typically have low cost burden. The patients most likely to need financial assistance are:

Uninsured patients who pay full retail

Patients on high-deductible plans before meeting their deductible

Patients requiring specialty injectable formulations (RediTrex auto-injector) that may face Tier 3 or specialty formulary placement

Step 1: Verify Insurance Formulary Placement

Before a patient picks up their prescription, confirm:

That generic oral methotrexate is on the patient's formulary (it almost always is on Tier 1–2)

Whether quantity limits apply (some plans limit to 4–8 tablets/month, which may not be enough for higher RA doses)

Whether prior authorization is required (rare for oral MTX at standard doses; more common for subcutaneous auto-injectors)

Your office's benefits verification process (or a specialty pharmacy) can complete this quickly. Addressing formulary issues before the first fill prevents frustration and treatment delays.

Step 2: Know the Patient Assistance Programs Available

Because methotrexate is an inexpensive generic, there is no manufacturer copay card (the original brand Rheumatrex is discontinued). However, several foundation-based assistance programs are available:

HealthWell Foundation — Systemic Lupus Erythematosus Fund: Provides copay assistance for lupus patients on methotrexate who have insurance. Phone: 1-800-675-8416. Website: healthwellfoundation.org

Good Days Patient Assistance Program: Available for eligible patients with insurance. Phone: 1-877-968-7233. Website: mygooddays.org. Requires proof of household income.

Partnership for Prescription Assistance (PPARx): Matches patients with federal, state, nonprofit, and manufacturer programs. Website: pparx.org

NeedyMeds.org: Searchable by drug name and diagnosis; lists both manufacturer and non-manufacturer assistance programs

Step 3: Recommend Prescription Discount Cards for Uninsured or Underinsured Patients

For patients without insurance or with high deductibles, prescription discount services can dramatically reduce out-of-pocket costs for generic methotrexate:

GoodRx (goodrx.com): Prices as low as $5 for a 30-day supply. Cannot be combined with insurance; use whichever is lower.

SingleCare (singlecare.com): Prices as low as $13.60 for 24 tablets at participating pharmacies including CVS, Walmart, Kroger

RxSaver, NeedyMeds, Blink Health: Additional price comparison tools with comparable pricing for generic methotrexate

Step 4: Optimize Prescribing Practices to Reduce Cost Burden

Write for a 90-day supply: Mail-order pharmacies often offer lower per-dose costs for 90-day fills and reduce dispensing fee frequency

Prescribe oral over subcutaneous where clinically equivalent: Oral tablets are cheaper and more widely available than RediTrex auto-injectors; reserve subcutaneous for patients with documented GI intolerance

Consider $4/$10 generic programs: Walmart and some other chains list methotrexate on their low-cost generic programs; useful for uninsured patients without coupon access

Helping Patients With Medicare

Methotrexate oral tablets are covered by all Medicare Part D plans. For Medicare patients:

Confirm Tier 1–2 placement on their specific plan; prices vary between plans

The 2026 Medicare Part D out-of-pocket cap is $2,100/year — methotrexate costs rarely approach this level

Low Income Subsidy (LIS/Extra Help) program: Eligible Medicare patients may pay $0–$4 per generic prescription. Refer eligible patients to SSA.gov/extrahelp

For more on supporting your patients' access to methotrexate, visit medfinder for providers or read our provider guide to helping patients find methotrexate in stock.